| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc. (BCAX) has 5 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. BCAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 377.2K | $8.76M | - | |
| COO | 191.6K | $4.45M | - | |
| CFO | 125.0K | $2.90M | - | |
| Other | 90.0K | $2.09M | - | |
| Other | 60.8K | $1.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | Cohlhepp Ryan52 | President And COO | Sale+OE | 50,500 | $18.06 | $911,841.99 | -5.7% | -11.3% | - | |
| Sep 29, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE | 33,807 | $14.75 | $498,653.25 | -100% | +19.0% | - | |
| Sep 15, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE | 15,829 | $11.49 | $181,875.21 | -100% | +61.3% | - | |
| Jun 16, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE | 15,829 | $10.43 | $165,096.47 | -100% | +13.8% | +119.5% | |
| Mar 14, 2025 | Meisner Lara71 | Chief Legal Officer | Sale+OE | 79,146 | $12.90 | $1,021,210.80 | -72.1% | -6.8% | +54.5% | |
| Sep 17, 2024 | Flynn James E62 | 10% Owner, Possible Members Of 10% Group | Buy | 70,000 | $18.00 | $1,260,000.00 | +4.1% | -35.7% | -59.5% | |
| Sep 16, 2024 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,833,000 | $18.00 | $32,994,000.00 | +35.8% | -31.5% | -55.7% |